FAPROTAB

This brand name is authorized in Nigeria.

Active ingredients

The drug FAPROTAB contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100351	Tablet	FAPROTAB 500 TABLETS TAB 500 mg 2 x 7	1 NF-PP-105252 FAPROTAB 500 TABLETS CIPROFLOXACIN CIPROFLOXACIN HYDROCHLORIDE 500MG UPS EXCIPIENTS: MICROCRYSTALLINE CELLULOSE BP, CROSCARMELLOSE SODIUM BP, MAIZE STARCH BP,POLYSORBATE 80 BP, MAGNESIUM STEARATE BP, PURIFIED TALC BP, FILM COAT QUINOLINE YELLOW IHS, ISOPROPYL ALCOHOL BP AND PURIFIED WATER BP A4-100351 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Imported Products 2x7 Prescription Only Medicine (POM) 1/24/2021 FADOB PHARMACEUTICAL (NIGERIA) LIMITED, 29,SALAMI KASUNMU STREET MOSAN IPAJA 8103344299 fadobpharm@yahoo.com Saga Lifesciences Limited, Survey No. 198/2 & 198/3, Chachrawadi Vasna, Tal. Sanand,Dist.: Ahmedabad Gujarat, India, India	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100351